Drugs / Double viral (MR) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02196285 | Sep → Dec 2015 | measles, rubella | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Double viral (MR) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02196285 ↗ |
| Modality | Vaccine | “double viral vaccine anti-measles and rubella (MR)” NCT02196285 ↗ |